Regional acetate kinetics and oxidation in human volunteers.

We have used a 3-h primed continuous infusion of [1,2-13C]acetate in five fasted (24 h) volunteers to quantify splanchnic and leg acetate metabolism (protocol 1). Fractional extraction of acetate by both tissues was high ( approximately 70%), and simultaneous uptake and release of acetate were observed. Labeled carbon recovery in CO2 was 37.9 +/- 2.3% at the whole body level, 37.7 +/- 1.5% across the splanchnic bed, and 37.3 +/- 2.9% across the leg. Furthermore, we calculated whole body labeled carbon recovery during 15 h of [1, 2-13C]acetate infusion in three volunteers (protocol 2). Whole body acetate carbon recovery in CO2 was significantly higher (66.7 +/- 4. 5%) after 15 h of tracer infusion than after 3 h. We conclude that acetate is rapidly taken up by the leg and splanchnic tissues and that the percent recovery of CO2 from the oxidation of acetate is heavily dependent on the length of acetate tracer infusion. In the postabsorptive state, labeled carbon recovery from acetate across the leg and the splanchnic region is similar to the whole body CO2 recovery.

[1]  J. Miles,et al.  Measurement of plasma acetate kinetics using high-performance liquid chromatography. , 1991, Analytical biochemistry.

[2]  G. Shulman,et al.  Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. , 1996, The Journal of clinical investigation.

[3]  M. Beylot,et al.  Assay of the concentration and stable isotope enrichment of short-chain fatty acids by gas chromatography/mass spectrometry , 1995 .

[4]  S. Coppack,et al.  Arteriovenous differences across human adipose and forearm tissues after overnight fast. , 1990, Metabolism: clinical and experimental.

[5]  M. Krempf,et al.  Kinetic aspects of acetate metabolism in healthy humans using [1-13C] acetate. , 1996, The American journal of physiology.

[6]  P. Paul,et al.  Plasma acetate turnover and oxidation. , 1979, The Journal of clinical investigation.

[7]  J. Wahren,et al.  Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. , 1991, The Journal of biological chemistry.

[8]  R. Wolfe,et al.  Recovery of labeled CO2 during the infusion of C-1- vs C-2-labeled acetate: implications for tracer studies of substrate oxidation. , 1990, The American journal of clinical nutrition.

[9]  F J Ballard,et al.  Production and utilization of acetate in mammals. , 1974, The Biochemical journal.

[10]  M. Hellerstein,et al.  Measurement of de novo hepatic lipogenesis in humans using stable isotopes. , 1991, The Journal of clinical investigation.

[11]  J. Miles,et al.  Metabolism of triacetin-derived acetate in dogs. , 1993, The American journal of clinical nutrition.

[12]  E. Pomare,et al.  Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. , 1985, The Journal of clinical investigation.

[13]  J. Miles,et al.  Systemic and regional acetate kinetics in dogs. , 1992, The American journal of physiology.

[14]  M. Elia,et al.  The contribution of the large intestine to blood acetate in man. , 1991, Clinical science.

[15]  D. Chinkes,et al.  Measurement of pyruvate and lactate kinetics across the hindlimb and gut of anesthetized dogs. , 1994, The American journal of physiology.

[16]  M. Krempf,et al.  Measurement of whole body acetate turnover in healthy subjects with stable isotopes. , 1994, Biological mass spectrometry.

[17]  L. Sidossis,et al.  A new correction factor for use in tracer estimations of plasma fatty acid oxidation. , 1995, The American journal of physiology.